Home Compounds MK-677
Non-peptide oral GH secretagogue WADA prohibited Investigational

MK-677.

Also known as: Ibutamoren · Ibutamoren mesylate · Nutrobal · Oratrope

The oral growth hormone secretagogue — with the deepest human trial data in its category, and the heaviest side-effect profile.

EP
Researched and edited by the Epti editorial team
Every claim labeled by confidence tier · reviewed quarterly · last updated May 20, 2026
01 · Quick overview

The TL;DR.

What it is
A non-peptide, orally active growth hormone secretagogue. It mimics ghrelin (the "hunger hormone") to drive sustained release of endogenous GH and IGF-1.
Half-life
~24 hours well-established — supports once-daily oral dosing
Typical dose
10–25 mg once daily, orally community
Status
Investigational new drug. WADA-prohibited. Not FDA-approved.
Who it's for
Individuals seeking oral GH/IGF-1 elevation for bulking, appetite stimulation, or recovery — who are willing to monitor blood glucose closely.
Biggest risk
Reliable degradation of insulin sensitivity. Fasting glucose climbs in nearly all users — daily monitoring is non-negotiable.

MK-677 (Ibutamoren) is a potent, orally active growth hormone secretagogue. By binding to the ghrelin receptor (GHSR-1a) in the pituitary gland and hypothalamus, it stimulates a sustained release of endogenous growth hormone and insulin-like growth factor 1 well-established.[1]

Unlike injectable peptides like Ipamorelin or CJC-1295, MK-677 is taken orally and has a long half-life of approximately 24 hours, allowing for once-daily dosing.[8] It is highly effective at raising IGF-1 levels, but it comes with significant side effects — most notably a massive increase in appetite, water retention, and a reduction in insulin sensitivity well-established.[2]

Not a SARM
MK-677 is frequently sold by vendors alongside SARMs (Selective Androgen Receptor Modulators), but it is not a SARM. It does not bind to androgen receptors and does not suppress natural testosterone production.
02 · Protocol & usage guide

How it's actually used.

Important
MK-677 is an investigational compound. The protocols below reflect community consensus and observational data — not medical advice.

Before you start

  • Identify the goal. MK-677 is primarily used for bulking due to its intense appetite-stimulating effects.
  • Understand the regulatory status. MK-677 cannot be legally prescribed or compounded in the US. Sourcing requires the unregulated research-chemical market.
  • Check your sport's rules. MK-677 is prohibited by WADA and most major sporting organizations.
  • Baseline bloodwork. Do not start MK-677 without knowing your baseline fasting blood glucose and HbA1c.

Standard community dosing

LevelDoseFrequency & routeCycle
Beginner / Anti-aging10 mg1× daily · oral3–6 mo
Intermediate / Bulking20 mg1× daily · oral3–6 mo
Advanced25 mg1× daily · oral3–6 mo

Doses above 25 mg do not significantly increase GH/IGF-1 further but do increase side effects (diminishing returns). community

Reconstitution math

N/A — MK-677 is an oral compound (liquid suspension or capsule). No reconstitution is required.

Dosing timing

Timing depends entirely on the user's goal regarding the appetite side effect:

  • To avoid hunger: take the dose immediately before bed. This allows the user to sleep through the most intense ghrelin spike. community
  • To utilize hunger (bulking): take the dose first thing in the morning to stimulate appetite throughout the day. community

Missed doses

  • Missed 1 day: take the normal dose the next day. Do not double-dose.
  • Missed 3+ days: resume the normal protocol.

Community consensus and real-world experience

In community discussions, MK-677 is highly regarded as a bulking tool because it forces a caloric surplus via intense hunger. Users report rapid initial weight gain (5–10 lbs in the first two weeks), almost entirely due to water retention and increased glycogen storage. community[11] The lethargy side effect is frequently discussed, with many users switching to nighttime dosing to mitigate daytime tiredness. community[14]

epti
Track your protocol

Log daily glucose, dose, and weight on one timeline.

MK-677 only works if you can catch insulin-resistance creep before it becomes permanent. Track every morning glucose reading next to your dose, weight, and HbA1c trend.

Join waitlist →
03 · Nutritional support & supplements

What to eat alongside.

Because MK-677 reliably decreases insulin sensitivity and raises fasting blood glucose, nutritional support is mandatory.

Macronutrient adjustments

  • Carbohydrates — monitor carbohydrate intake to avoid exacerbating insulin resistance. High-glycemic diets on MK-677 rapidly degrade metabolic health.

Micronutrient adjustments

No data available — MK-677 does not have specific micronutrient dependencies.

Synergistic supplements

  • P-5-P (Vitamin B6) — 100–300 mg daily. MK-677 can mildly elevate prolactin; P-5-P is often used to keep prolactin in range. community

Protective supplements

  • Berberine — 500 mg taken 2–3× daily with carbohydrate-containing meals. Acts as a glucose disposal agent to help manage blood sugar. community
04 · Safety, interactions & side-effects

What can go wrong.

Critical
MK-677 reliably degrades insulin sensitivity. Daily monitoring of fasting blood glucose is non-negotiable.

Reported side effects

EffectFrequencySeverityManagement
Insulin resistance Very common well-est. Monitor blood glucose; use GDAs
Extreme appetite Very common well-est. Dose at bedtime if unwanted
Water retention Very common community Monitor sodium; ensure hydration
Lethargy Common community Dose at bedtime

Drug interactions

No formally documented drug interactions. Caution is advised when combining with medications that affect blood glucose (e.g., metformin, insulin) — the additive effect on insulin axis is unknown.

Contraindications

Absolute
  • Pre-existing diabetes or pre-diabetes — MK-677 will worsen glycemic control
  • Active malignancy — sustained IGF-1 elevation provides a pro-growth environment
Relative
  • History of severe edema or congestive heart failure (water retention)

Red flags

Stop immediately if
  • Fasting blood glucose consistently reads above 100 mg/dL (5.5 mmol/L)
  • Severe, pitting edema (swelling) in the lower extremities

Pregnancy, lactation & fertility

No data available — MK-677 has not been studied in pregnant or lactating women, nor has its effect on human fertility been evaluated. It should be strictly avoided in these populations.

Theoretical risks

  • Pancreatic beta-cell exhaustion. Long-term, sustained stress on the insulin axis could theoretically lead to permanent beta-cell dysfunction (Type 2 diabetes) in susceptible individuals.
05 · Stacks & combinations

What to combine it with.

Stack 1 · bulking

MK-677 + LGD-4033 or RAD-140

MK-677 20–25 mg/day SARM (dose varies) 8–12 wk cycle

A common — though high-risk — bodybuilding stack. The SARM drives muscle protein synthesis; MK-677 drives appetite, allowing the user to eat in a massive caloric surplus. Both compounds negatively impact health markers. community[11]

Stack 2 · sustained GH

MK-677 + CJC-1295 (with DAC)

MK-677 10–25 mg/day CJC-1295 DAC 2 mg/wk

Combines the oral ghrelin mimetic with a long-acting GHRH mimetic to hit both pathways simultaneously for sustained GH/IGF-1 elevation. community[13]

Anti-pattern stacks — avoid

Moderate
  • MK-677 + Ipamorelin / GHRPs. Both compete for the same GHSR-1a receptor. Stacking them provides no additional benefit and increases the risk of receptor desensitization.
High
  • MK-677 + high-carb diet. Rapidly accelerates the onset of severe insulin resistance.
06 · Body composition & training

How to train on it.

MK-677 is primarily used during hypercaloric (bulking) phases. Its effects are gradual and depend heavily on diet and training adherence.

Expected trajectory

Weeks 1–2Intense hunger, rapid weight gain (water/glycogen), lethargy.
Weeks 3–6Sustained weight gain, improved sleep, potential joint relief from water retention.
Weeks 8–12+Gradual improvements in lean-mass retention and recovery.

Training adjustments

  • Expect a pump. The increased intracellular water and glycogen often lead to intense, sometimes painful muscle pumps during training.

Cut / recomp / bulk contexts

  • Cut: Poor choice. The intense appetite stimulation makes adhering to a caloric deficit extremely difficult, and water retention masks fat loss.
  • Recomp: Acceptable at low doses (10 mg) if appetite can be controlled.
  • Bulk: Excellent. Ghrelin mimicry is highly effective at forcing a caloric surplus for individuals who struggle to eat enough.
07 · Storage, handling & accessibility

How to store it.

Liquid suspension
Room temp

Store at room temperature, away from direct sunlight. Do not refrigerate — the compound may crash out of solution.

Capsules
Cool & dry

Store in a cool, dry place. BUD typically 2 years from manufacture.

Light & freeze sensitivity

  • Light — keep away from direct sunlight.
  • Freeze — do not freeze liquid suspensions.

Sourcing & legal access

  • United States. Investigational new drug. Not approved for human use.
  • Cost-per-cycle (USD). Typically $40–$80 per month via research-chemical vendors.
  • Global. Not approved as a human therapeutic in any major jurisdiction.
08 · Bloodwork monitoring

What to track.

Daily home glucose monitoring is required for this compound. A standard over-the-counter glucometer is sufficient. Check every morning, fasted.

Baseline panel

MarkerWhy it mattersRed flag
Fasting glucose & HbA1cEnsures baseline insulin sensitivity is healthy.FG > 100 mg/dL
IGF-1Establishes baseline to measure efficacy.
ProlactinEstablishes baseline; MK-677 can mildly elevate it.Above range

Mid-cycle panel

MarkerWhy it mattersRed flag
Fasting glucoseMonitors for GH-induced insulin resistance.FG > 100 mg/dL
IGF-1Confirms the compound is active and elevating levels.
ProlactinMonitors for elevation.Above range

Post-cycle panel

MarkerWhy it mattersRed flag
Fasting glucose & HbA1cEnsures insulin sensitivity has returned to baseline.Sustained elevation

Doctor handoff

Print this. Hand it to your physician.
Patient is utilizing MK-677 (Ibutamoren), an investigational oral growth hormone secretagogue. The compound stimulates endogenous GH release and is known to degrade insulin sensitivity. Please monitor IGF-1 to assess efficacy and fasting glucose / HbA1c to ensure glycemic control remains stable.
09 · Comparison

vs. similar compounds.

MK-677IpamorelinCJC-1295 (No DAC)Exogenous HGH
ClassOral GHSR agonistGHRP (ghrelin mimetic)GHRH mimeticBio-identical hormone
RouteOralSCSCSC
AppetiteExtremeNoneNoneNone
Insulin impactHigh riskLow riskLow riskHigh risk
Half-life~24 hours~2 hours~30 min~10–20 min

When to pick MK-677

Choose MK-677 only if oral administration is mandatory or if extreme appetite stimulation is desired for bulking.

When to pick Ipamorelin

Choose Ipamorelin for a clean, side-effect-free GH pulse — especially for anti-aging and sleep improvement.

When to pick CJC-1295

Choose CJC-1295 to stack with Ipamorelin to amplify the pulse via the GHRH pathway.

When to pick exogenous HGH

Choose HGH for exact bio-identical replacement — typically prescribed by a physician for diagnosed deficiency.

10 · Deep dive

What the mechanism looks like.

Mechanism of action

MK-677 (Ibutamoren mesylate) is a non-peptide spiropiperidine that acts as a potent, orally active, selective agonist of the GHSR-1a. By mimicking ghrelin, it stimulates the pituitary gland to release GH. Crucially, it amplifies the natural pulsatile release of GH rather than causing a continuous, unnatural elevation.[6]

Pharmacokinetics

MK-677 has excellent oral bioavailability (over 60%). Following a single oral dose, it produces a sustained increase in GH and IGF-1 levels. The terminal half-life is approximately 24 hours, which supports once-daily dosing.[8]

Active metabolites

No data available — specific active metabolites in humans are not fully characterized.

Human clinical trials

Unlike many peptides in this category, MK-677 has a robust human clinical trial history — including a 2-year randomized controlled trial in older adults.

StudynDurationPopulationResult
Copinschi (1996)Small7 daysHealthy young men↑ GH pulsatility & IGF-1; transient cortisol/prolactin rise
Chapman (1996)Small14 daysHealthy elderlyRestored GH/IGF-1 to young-adult levels
Smith (1997)SmallSingle doseHealthy volunteersEstablished 24-h half-life
Murphy (1998)814 daysDiet-restricted volunteersReversed diet-induced nitrogen wasting
Svensson (1998)248 weeksObese young malesIncreased bone turnover markers
Nass (2008)652 yearsHealthy older adults↑ IGF-1 & fat-free mass; ↑ fasting glucose
Sevigny (2008)41612 monthsAlzheimer's patientsRaised IGF-1; did not slow disease
Adunsky (2011)1236 monthsHip-fracture patients↑ IGF-1 & lean mass; no functional benefit

Open questions

  • Does long-term pancreatic beta-cell stress from sustained MK-677 use lead to permanent insulin resistance in young, healthy athletic populations? (No longitudinal data exists.)
11 · FAQ

Frequently asked.

Is MK-677 a SARM?

No. It is often sold alongside SARMs, but it is a growth hormone secretagogue. It does not affect testosterone levels.

Will MK-677 make me fail a drug test?

Yes. It is banned by WADA and will cause a failure on any test looking for performance-enhancing drugs.

Why am I so tired on MK-677?

Lethargy is a very common side effect, likely related to the sustained elevation of IGF-1 and alterations in blood glucose dynamics. Taking the dose at night can help mitigate daytime lethargy.

Do I need to cycle off MK-677?

While it doesn't desensitize the GH receptor quickly, users must cycle off if their fasting blood glucose begins to climb. Many users run it for 3–6 months.

Does MK-677 cause water retention?

Yes — significant water retention is almost universal, often resulting in a puffy face ("moon face") and sudden weight gain on the scale.

12 · Regulatory & legal status

Where it stands, by jurisdiction.

Last verified · May 17, 2026

AgencyStatusDetails
US FDAUnapprovedInvestigational new drug. Not approved for human use.
US DEANot scheduledNot a controlled substance.
UK MHRAUnapprovedNot licensed as a medicine.
EU EMAUnapprovedNot authorized for medical use.
Health CanadaUnapprovedNot authorized for sale.
Australia TGARestrictedUnapproved. Schedule 4 — possession without prescription is restricted, but no TGA-approved product exists.
WADABannedProhibited under S2 (Peptide Hormones, Growth Factors).
NCAABannedFollows WADA guidelines.
NFL, MLB, NBABannedClassified as a performance-enhancing substance.
13 · Decision tree

Is MK-677 for you?

Are you a drug-tested athlete?
Yes
STOP — MK-677 is banned by WADA
No → Do you have pre-diabetes or family history of diabetes?
Yes
STOP — MK-677 degrades insulin sensitivity
No → Are you willing to inject peptides subcutaneously?
Yes
Consider Ipamorelin/CJC-1295 for cleaner side-effect profile
No → Is your goal massive appetite for bulking?
Yes
MK-677 is highly effective for this use case
No
Side effects likely outweigh benefits
Q1. Are you subject to anti-doping testing?
If yes, stop. MK-677 is banned by WADA and will result in a doping violation.
Q2. Do you have pre-diabetes or family history of diabetes?
If yes, stop. MK-677 reliably degrades insulin sensitivity and will worsen glycemic control.
Q3. Are you willing to inject peptides subcutaneously?
If yes, injectable peptides like Ipamorelin offer a much cleaner side-effect profile with no impact on appetite or insulin sensitivity.
Q4. Is your primary goal massive appetite stimulation for bulking?
If yes, MK-677 is highly effective for forcing a caloric surplus. If no, the side effects likely outweigh the benefits.
14 · References

What we cited.

  1. Murphy M.G. et al. (1998). MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab. 83(2):320–325. PMID: 9467533.
  2. Nass R. et al. (2008). Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. Ann Intern Med. 149(9):601–611. PMID: 18981485.
  3. Sevigny J.J. et al. (2008). Growth hormone secretagogue MK-677: no clinical effect on AD progression. Neurology. 71(21):1702–1708. PMID: 19015485.
  4. Adunsky A. et al. (2011). MK-0677 for hip-fracture recovery: a phase-IIb study. Arch Gerontol Geriatr. 53(2):183–189. PMID: 21035201.
  5. Svensson J. et al. (1998). MK-677 increases markers of bone formation and resorption in obese young males. J Bone Miner Res. 13(7):1158–1166. PMID: 9661080.
  6. Copinschi G. et al. (1996). Effects of a 7-day treatment with MK-677 on 24-hour GH profiles. J Clin Endocrinol Metab. 81(8):2776–2782. PMID: 8768828.
  7. Chapman I.M. et al. (1996). Stimulation of the GH–IGF-1 axis by daily oral MK-677 in healthy elderly subjects. J Clin Endocrinol Metab. 81(12):4249–4257. PMID: 8954023.
  8. Smith R.G. et al. (1997). Peptidomimetic regulation of growth hormone secretion. Endocr Rev. 18(5):621–645. PMID: 9331546.
  9. Reddit r/sarmsourcetalk. "MK-677 help." Accessed May 17, 2026.
  10. Reddit r/Peptides. "CJC 1295 w/DAC + MK677 combo." Accessed May 17, 2026.
  11. Reddit r/sarmsourcetalk. "Is there anything mk-677 shouldn't be taken with?" Accessed May 17, 2026.

Track your protocol.

Epti is the first training app built around your peptide protocol — workouts, dosing, side effects, and bloodwork that actually talk to each other.